Evoke Pharma
EVOK
$0.45
Share price
2.27%
Change (1 day)
-76.68%
Change (1 year)
Categories
Evoke Pharma (EVOK) - Cash on Hand
Cash on Hand as of December 2023 : $4.73 M
According to Evoke Pharma
's latest financial reports the company has $4.73 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Evoke Pharma - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $9.84 M | 7.64% |
| 2021-12-31 | $9.14 M | 13.33% |
| 2020-12-31 | $8.06 M | 42.46% |
| 2019-12-31 | $5.66 M | 6.48% |
| 2018-12-31 | $5.31 M | -30.74% |
| 2017-12-31 | $7.67 M | -14.74% |
| 2016-12-31 | $9 M | 3.63% |
| 2015-12-31 | $8.69 M | -38.6% |
| 2014-12-31 | $14.15 M | -41.5% |
| 2013-12-31 | $24.19 M | 20756.88% |
| 2012-12-31 | $0.11 M | -86.6% |
| 2011-12-31 | $0.86 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | $0.22 B | 4,565.56% | 🇺🇸 USA |
 Amphastar Pharmaceuticals AMPH | $0.25 B | 5,318.50% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.17 B | 3,538.92% | 🇺🇸 USA |
 Ironwood Pharmaceuticals
IRWD | $92.15 M | 1,844.41% | 🇺🇸 USA |